Aptamer extends agreement with genetic medicines customer
Key Highlights: Aptamer Group announced that a genetic medicines customer has selected to progress to the final commercial development phase for Optimer delivery vehicles. The performance of these delivery vehicles has been validated by the customer, indicating that the Optimer…
Cherwell highlights environmental monitoring products at conference – European Pharmaceutical Manufacturer
Key Highlights: Cherwell is to highlight its range of products for environmental monitoring and process validation in sterile medicinal product manufacturing and how these complement other products within its parent company AnalytiChem. Cherwell will be exhibiting at Pharmig’s 32nd Annual Conference,…
Xeltis expands leadership team with new VP of Clinical Business Development
Key Highlights: Xeltis announced that it has appointed Luc Verhees as its new vice president of Clinical Business Development. Luc’s appointment further strengthens the company’s leadership team, as Xeltis expands its clinical presence following the approval of an Investigational…
Bespak and Orbia unite to accelerate transition to climate-friendly inhalers
Key Highlights: Bespak and Orbia Advance Corporation announced a collaboration intended to accelerate the transition to climate-friendly inhalers utilising Orbia Fluor & Energy Materials’ low global warming potential propellant known as Zephex 152a. The shared aim of the collaboration is to advance understanding and…
iotaSciences launches fast single-cell cloning platform for gene therapy
Key Highlights: iotaSciences announced the upcoming launch of its newly developed Single-Cell Cloning Platform XT at the Cell 2024 event in London (UK) from November 6-8, 2024. The Single-Cell Cloning Platform XT is an instrument based on the existing Single-Cell…
Starget Pharma secures $5.1 million investment for targeted cancer therapy
Key Highlights: ARC Innovation announced the successful $5.1 million funding round of Starget Pharma, a startup specialising in precise cancer diagnosis and targeted radiotherapy. The investment was secured from Cancer Focus, a fund established in collaboration with the MD Anderson…
Transgene and ProBioGen to advance individualised cancer vaccines
Key Highlights: Transgene and ProBioGen announced that the companies have entered into a license agreement for ProBioGen’s AGE1.CR.pIX suspension cell line. This partnership aims to add value by combining ProBioGen’s specific production technology with the manufacturing capabilities of Transgene’s individualised…
Synaffix collaborates with BigHat to develop machine learning ADC
Key Highlights: Synaffix collaborates with BigHat Biosciences for the development of a machine learning-designed ADC. The collaboration underscores Lonza’s commitment to helping customers deliver innovative new therapies to patients by offering a comprehensive service offering for differentiated ADCs BigHat’s…
.png?cb=05fbba036ffdc3f890d18d3f5a2a3491&w=1200)
Takeda presents positive proof-of-concept results for IgAN patients
Key Highlights: Takeda announced positive interim results from a Phase 3-enabling proof-of-concept study for mezagitamab (TAK-079) in patients with primary immunoglobulin A nephropathy (IgAN). Mezagitamab is a fully human, anti-CD38 IgG1 monoclonal antibody that depletes plasma cells, plasma blasts, and…
Naobios and Sumagen optimise HIV vaccine candidate for scale-up
Key Highlights: Naobios and Sumagen Canada announced the production of the HIV-1 vaccine candidate at bench scale. This key milestone puts Naobios in a position to scale up the production of Sumagen’s HIV-1 vaccine candidate following a partnership agreement signed in…
Three part alliance introduce pharma bottle made with wood-based plastics
Key Highlights: UPM Biochemicals, Selenis and Bormioli Pharma have partnered to produce the world’s first pharmaceutical bottles made from partially wood-based PET. The bottle uses standard PET which is made with UPM’s world first wood-based BioMEG, UPM BioPuraTM, to…
New Berry bottle complements preservative-free eye treatment
Berry Global has launched a new easy-squeeze ophthalmic 10ml bottle that has been qualified for use with Aptar Pharma’s globally recognised Ophthalmic Squeeze Dispenser (OSD). The new bottle from Berry provides a reliable and user-friendly complement to the OSD, which…
VALANX and FinaBio partner for rapid conjugate vaccine development
Key Highlights: VALANX Biotech and FinaBio sign joint licensing agreement to commercialise ready-to-conjugate vaccine carrier protein CRM197 will enable rapid development of conjugate vaccines. The new product enables the rapid, high-efficiency conjugation of carrier proteins to polysaccharide antigens for the…
DeSci Labs wins gold at the Lab Awards
Key Highlights: DeSci Labs has won the Best Automation & Data Innovation – Organisation prize at this year’s Lab Awards, held at Lab Innovations 2024. DeSci Labs picked up the win in the Best Automation & Data Innovation category…
R&D funding and capital gains: What the budget means for life sciences
Key Highlights: The Chancellor pledged to fund Britain’s membership of Horizon, the European Union’s research and innovation programme, which is worth more than £80 billion to Britain’s science and technology sectors. The government’s flagship announcement for the sector was…
Sterling expands GMP ADC manufacturing capacity at Deeside
Key Highlights: Sterling Pharma Solutions, announced the second phase of an expansion strategy at its Deeside, UK site to support antibody-drug conjugate (ADC) development, with a more than £10 million investment to increase GMP bioconjugation capacity. A new 2,300-square…
Ardena expands bioanalytical services in Europe
Key Highlights: Ardena announced a expansion of its bioanalytical services in the Netherlands, including a new bioanalytical lab at Ardena’s Pivot Park facility in Oss and new GLP capabilities in Assen. The addition of the new Oss lab will complement Ardena’s current bioanalytical…
PLG acquires Callisto to strengthen regulatory services in the UK and EU
Key Highlights: ProductLife Group (PLG) announced the acquisition of Callisto, a UK-based consultancy specialising in Regulatory Affairs (RA), Pharmacovigilance (PV) and GMDP services within multiple regulated sectors. Callisto has a strategic geographical presence in both the UK and Ireland…
Logical Biological expands at Discovery Park after trade growth
Key Highlights: Logical Biological has settled into larger, upgraded laboratory space at Discovery Park, marking its third move within the science and innovation campus. This expansion reflects the company’s remarkable growth, which has seen a 170% increase in international trade…
Terumo automates manufacturing to expand cell & gene therapies
Key Highlights: Terumo advances adoption of automated manufacturing to bring novel cell and gene therapies to more Latin American patients. The company is starting in Brazil, Colombia and Mexico, seeking to improve efficiency and cost-effectiveness in the manufacturing process for…
.png?cb=b9fef6a30da725fdb660e50347bf76cb&w=1200)
CluePoints appoints Richard Young as chief strategy officer
Key Highlights: CluePoints announced that Richard Young has been appointed as its new chief strategy officer. Young possess 30 years of experience in clinical data management with his most recent role being vice president, Strategy, Clinical Data, at Veeva Systems. …
.png?cb=223fb2b54ac3e83a8654a4a06fbff5fa&w=1200)
AstraZeneca drug approved in the EU for rare immune disease
Key Highlights: AstraZeneca’s drug Fasenra has been approved in the EU as an additional treatment for adults with eosinophilic granulomatosis with polyangiitis (EGPA), a rare immune condition that can cause organ damage. Results from the MANDARA Phase III trial showed that…
Cold Chain acquires Tower to expand global service network
Key Highlights: Cold Chain Technologies has acquired Tower Cold Chain, to expand its product portfolio and global service network. From its United Kingdom headquarters and network of more than 20 service hubs across five continents, Tower supports its blue-chip pharmaceutical…
Ten businesses embark on Discovery Spark programme
Key Highlights: Ten entrepreneurial life science and technology businesses have begun the immersive Discovery Spark programme, with a prize package worth over £50,000 up for grabs. The Discovery Spark programme equips early stage life science and technology businesses with…
.png?cb=acb3c8ae5eea4da3c8fe0ffed6a122aa&w=1200)
Thermal fluid expert launches high flash point cleaning fluid
Key Highlights: Global Heat Transfer, has launched a new cleaning and flushing fluid — Globaltherm C1 HF. Globaltherm C1 HF helps to rid heat transfer systems of potentially harmful contaminants and effectively displaces and flushes out waste. C1 HF can also…
.png?cb=f6ca88ed2f154258e1a517ab39a3630d&w=1200)
Avantor and NIBRT extend partnership to address biopharma challenges
Key Highlights: Avantor and NIBRT have formed a new partnership to supply advanced Masterflex equipment, essential products and expert training to foster innovations in biopharma manufacturing. The new collaboration will focus on addressing urgent bottlenecks in biopharma manufacturing, particularly in downstream…
ApiJect receives grant to develop low-cost injection device for LMICs
Key Highlights: ApiJect announced it has been awarded an initial grant of $425,000 from the Bill & Melinda Gates Foundation to develop low-cost blow-fill-seal prefilled injection devices. The grant will fund the design and development of an affordable, multi-month contraceptive…
.png?cb=39ea4f38c76ab98512a044ed592d46c9&w=1200)
Coronado Research appoints new CSO to expand service offerings
Key Highlights: Coronado Research announced that Professor Jennifer Visser-Rogers has been appointed as chief scientific officer, bringing with her a broad portfolio of scientific achievement across academia and industry. Jennifer is the incoming president of the International Biometrics Society, British and Irish…
.png?cb=cdabc217eecebc98422fac7da6e724c8&w=1200)
FDA expands Pfizer RSV vaccine to all high-risk adults
The US Food and Drug Administration (FDA) has expanded approval for Pfizer’s respiratory syncytial virus (RSV) vaccine, Abrysvo, to include adults aged 18–59 years who are at higher risk of lower respiratory tract disease from the virus due to chronic…
.png?cb=9bf61d29a3e44cb7cd942e5ea8c6b371&w=1200)
BirchBioMed clinical program reaches final stage to minimise burn scars
Key Highlights: BirchBioMed announced the authorisation from Health Canada to conduct its Phase II/III randomised clinical trial of a naturally based compound, FS2, at multiple centres of expertise throughout Canada. FS2, a kynurenic acid product to be used as…
.png?cb=36325cd85918e6c4ccafc11611b5a255&w=1200)
Bioptimus and Proscia to accelerate AI innovation in drug development
Key Highlights: Bioptimus announced that its H-optimus-0 foundation model is now integrated into Proscia’s Concentriq Embeddings, enabling data scientists and researchers in pathology and life sciences to achieve breakthroughs in AI development. H-optimus-0 is an AI foundation model tailored specifically for…
.png?cb=e03c889d118e46099c96221d5673151e&w=1200)
SynaptixBio calls for genetic screening to include untreatable conditions
Key Highlights: SynaptixBio calls for new genetic screening programme, the Generation Study, to be extended to test for untreatable conditions. The study will offer whole genome sequencing to newborns using their blood samples to test for over 200 rare genetic…
.png?cb=1cf903ca7fc9e4f6c868338a99edd595&w=1200)
New service to profile how cells produce energy in real-time
Key Highlights: University of Birmingham Enterprise announces the launch of Biocell Energetics, to provide profiling and testing services that assess, in real-time, how living cells produce energy. Biocell Energetics will provide services including real-time metabolic profiling of cells, metabolic…
.png?cb=6a57af55e2c936be3d43c509680f21e5&w=1200)
Bormioli partners with Chiesi to supply Carbon Capture PET packaging
Key Highlights: Bormioli announced a partnership with Chiesi, an international, research-focused biopharmaceutical company (Chiesi Group), to supply Carbon Capture PET bottles. These will be used to package a medication indicated for the prophylaxis and treatment of seasonal and perennial allergic…
.png?cb=121c009d4010a739e0dc7cfdfddbdf44&w=1200)
SGS launches consultancy services to accelerate clinical trial submissions
Key Highlights: SGS has launched its ‘CDISC Open Rules Consultancy’, a new service designed to transform and accelerate clinical trial submissions. SGS’s CDISC Open Rules Consultancy services guide users through every step of implementation from initial consultation and strategic planning to full project…
The FemTech Series: Analysing the risk of breast cancer recurrence
In this episode of The FemTech Series, you can hear Olivia Friett, editor of Medical Plastics News talk to Hemmel Amrania PhD, CEO of Digistain, a company that has won multiple awards for its transformative breast cancer biomarker analytics. ×
Veranova expands advisory board with appointment of two industry leaders
Key Highlights: Veranova announced the appointment of two distinguished industry leaders, Dr. Rajni Aneja and Dr. Bradley L. Pentelute, to its advisory board. Dr. Rajni Aneja is a seasoned physician executive and strategic advisor, bringing a wealth of experience…
.png?cb=5fca4440c83acd3a16ffbb6ccea63c40&w=1200)
Yourgene Health Cystic Fibrosis Base assay receives IVDR accreditation
Key Highlights: Yourgene Health announced that it has received accreditation under the new EU requirements of the in vitro diagnostic regulation (IVDR) for the Yourgene Cystic Fibrosis Base assay. The Yourgene Cystic Fibrosis Base assay uses amplification-refractory mutation system technology and genetic analysers to detect point mutations, insertions or…
MGS accelerates customer speed-to-market with fast-track tooling
Key Highlights: MGS is expanding its innovative Fast-Track Tooling Program, to debut in the North American market, designed to accelerate product development timelines and reduce costs for pharmaceutical, diagnostic and medtech companies. The tooling methodology uses readily available assets beginning…
.png?cb=5c27ba90dbd8889107ed19e804d2c2a4&w=1200)
Johnson & Johnson expands treatment options for inflammatory diseases
Johnson & Johnson (J&J) has announced that it has taken over all sales, marketing, and distribution responsibilities for Remicade (infliximab) and Simponi (golimumab) in the UK. Infliximab is an anti‑inflammatory medicine indicated for the treatment of rheumatoid arthritis (RA), Crohn’s disease…
VR project to tackle skills shortage in UK medicines manufacturing
Key Highlights: A new initiative, known as Resilience, has been launched to address the acute skills shortage faced by the medicines manufacturing industry in the UK. Resilience will use virtual reality to train in laboratory skills and support the NHS’…
Sheffield bowel cancer patients to try out personalised ‘vaccines’
Key Highlights: Patients receiving treatment for bowel cancer at Sheffield Teaching Hospitals NHS Foundation Trust will have the chance to try personalised ‘vaccines’ thanks to the launch of a NHS “matchmaking” service. The landmark Cancer Vaccine Launch Pad aims to…
Biometric ID drives security and efficiency in pharma manufacturing
Paul Shu of ARISTA Corporation, explains how pharma manufacturers are increasingly turning to wearable biometric ID products to securely speed authentication in a hands-free manner. Key Highlights: Pharmaceutical manufacturers are increasingly turning to wearable biometric ID products like wrist-worn Nymi…
Veolia Water Technologies opens Life Science Centre of Excellence
Key Highlights: As part of the group’s GreenUp strategic plan, Veolia Water Technologies is opening this centre to drive water treatment innovation, growth and training in Europe and beyond for the pharmaceutical, science and healthcare markets. The centre aims to…
.png?cb=28b03f8e2d2e18445632931c276218bf&w=1200)
Global study shows cefiderocol’s success in treating resistant infections
Key Highlights: Shionogi & Co., Ltd. shared new data at IDWeek 2024 from the PROVE study, the largest global real-world evidence review of Fetroja/Fetcroja (cefiderocol). The study looked at how cefiderocol is used to treat seriously ill adult patients with…
.png?cb=e108c253ba26e82dfeaf6b4851666b9b&w=1200)
Ardena signs agreement to acquire Catalent manufacturing facility
Key Highlights: Ardena announced it has signed a definitive agreement to acquire Catalent’s facility in Somerset, NJ. This acquisition will significantly enhance Ardena’s capabilities in downstream late-stage and small-scale commercial manufacturing of oral drug products. The FDA-approved Somerset…
.jpg?cb=96d0f2922962c8ea27588e31ad360e76&w=1200)
How can you use content to achieve goals beyond the usual scope?
Nataliya Andreychuk, CEO and co-founder of Viseven, explores how to leverage content in pharma beyond traditional marketing goals, highlighting customer education, societal influence, product development and policy impact. Key Highlights: Content can enhance customer education, influence societal views, drive product development,…
.png?cb=35ecb52bd702083f2fb96f6b21c631bf&w=1200)
Ellorarxine enters human trials and shows promise for MND sufferers
Key Highlights: Ellorarxine, a novel drug compound developed by Nevrargenics, has demonstrated antioxidant and anti-inflammatory effects, which make it a promising new therapy for treating ALS. The results showed that Ellorarxine increases MAP2 expression at low concentrations, induces neurite outgrowth, ameliorates…
.png?cb=c4d96139be5741259d96c6ea8369aa5d&w=1200)
Enhancing drug delivery: Innovation for the future
Beth Tran, global business manager, CR Excipients, Colorcon, explains how innovations in controlled release systems, film coatings and functional excipients are driving the future of drug delivery. Key Highlights: Innovations in controlled release, film coatings, functional excipients and desiccant packaging are leading…
ReiThera delivers 700 vaccine doses to combat Marburg outbreak
Key Highlights: In partnership with the Sabin Vaccine Institute, ReiThera provided its investigational Marburg vaccine to Rwanda to support the ongoing outbreak response. The initial shipment of approximately 700 vaccine doses will be used in a trial targeting frontline workers,…
.png?cb=d6c7fb121c0f9d1f27dec5a0717dad7f&w=1200)
Thermo Fisher showcases expanded biopharma services at CPHI Milan
Key Highlights: Thermo Fisher Scientific will showcase its latest innovations enabling the molecule-to-medicine journey and host a series of sessions that feature industry developments during CPHI Milan 2024. To help accelerate pre-clinical oral drug development, Thermo Fisher expanded sites in Cincinnati,…
Mapping the counterfeit and diversion epidemic in the pharma industry
Stephan Von Schilcher, global strategic account manager at Systech, discusses the repercussions of counterfeit drug epidemic on patients and what pharma companies must to combat the problem. Key Highlights: According to the WHO, the drug diversion and counterfeiting industry generates…
.png?cb=1122c5facfe82ddb149fa3f4b29fbc3b&w=1200)
Curve Therapeutics enhances leadership with R&D appointment
Key Highlights: Curve Therapeutics announced the appointment of Rab Prinjha, PhD, as chief research and development (R&D) officer. This continues Curve’s strong momentum expanding its leadership team following the recent appointments of Andre Hoekema and Cora Griffin, joining as…
.png?cb=a4a1b099d0a21b46aa5f793344629209&w=1200)
Norstella introduces a fully integrated data asset for biopharma
Key Highlights: Norstella has unveiled NorstellaLinQ, the biopharma industry’s first fully integrated data asset combining both real-world data (RWD). The data asset includes open and closed claims, lab results and structured and unstructured electronic medical records (EMR). In a recent…
.png?cb=6f2f67790ea4014b8e736741c9d79ecc&w=1200)
Honeywell to power DevPro’s low-emission respiratory inhaler
Key Highlights: Honeywell Energy is partnering with DevPro Biopharma to develop an innovative respiratory inhaler that enables individuals to manage their respiratory conditions offering significant reductions in carbon emissions. DevPro Biopharma’s new albuterol inhaler will reduce carbon emissions by 99.9% compared…
.png?cb=9f6793dc8beb8f56ee5a158e464d2048&w=1200)
Nipro launches D2F glass vials with Stevanato EZ-fill technology
Key Highlights: Nipro PharmaPackaging announced the launch of its innovative D2F (Direct-to-Fill) glass vials which are powered by Stevanato Group’s advanced EZ-fill technology, offering a high-quality ready-to-use (RTU) solution. D2F glass vials are washed, depyrogenated, packaged in nest & tub…
Informa and Ipack Ima form strategic alliance to boost synergy
Key Highlights: A synergic collaboration between Informa Markets and Ipack Ima S.r.l. was announced in Milan (Italy) to become a single global reference point for processing and packaging companies. The deal aims to develop joint international promotion and step up…
.png?cb=c6c3a37281ed6b4c2443b5c1ff641531&w=1200)
Innovation and the future of life science at Pharmintech
Key Highlights: A press conference took place in Milan to announce the new Pharmintech fair powered by Ipack Ima. The press conference adopted a round table format, with the participation of Sergio Dompé, Alberto Bartolini, Valerio Soli and Rossano Bozzi….
ACG accelerates European growth with major expansion in Croatia
Key Highlights: ACG is set to expand its footprint in Europe with significant upgrades to its Croatian operations. The expansion includes increased production capacity at ACG Capsules’ Croatian facility and the opening of new warehousing and slitting facilities by ACG…
A new era of biopharmaceutical packaging solutions
James Bury, director technology at Tjoapack, examines the increasing need for innovative solutions in pharmaceutical packaging, emphasising novel approaches and emerging technologies that address changing packaging requirements. Key Highlights: Packaging innovation is becoming more important due the increasing prevalence of sensitive…
.png?cb=ae8cc1a6fc22563458b6b55c9a7bcdd2&w=1200)
Mestag collabs with MSD to identify targets for inflammatory diseases
Key Highlights: Mestag Therapeutics announced that it has entered into a license and collaboration agreement with MSD to identify novel targets for the development of therapies against inflammatory diseases. Mestag will employ its Reversing Activated Fibroblast Technology (RAFT) platform, a…
.png?cb=3716698b1bc86dde820c6fa3ca51f0f0&w=1200)
Exothera appoints new CEO for refreshed strategic vision
Key Highlights: Exothera has announced the appointment of a new CEO, Cédric Volanti. He has an international track record and holds several executive positions in the cell and gene therapy at SGS, PharmaCell, Delphi Genetics (Belgium) and Novasep. Volanti will…
.png?cb=eeb958feef24b9f04ee0ba7087cf0d00&w=1200)
Lonza nominates David Meline as Independent Board Member
Key Highlights: Lonza’s board of directors announced the nomination of David Meline as an Independent Member of the Board. Meline brings extensive governance, financial and industry experience to Lonza’s Board of Directors, having served as a CFO for three publicly…
SGS brings advanced drug development solutions to CPHI Milan
SGS, a testing, inspection and certification company, announced it will be an exhibitor at the Convention on Pharmaceutical Ingredients (CPHI) Milan 2024. SGS experts will be on hand at Fiera Milano from October 8-10, 2024, to share insights and solutions spanning…
Bormioli Pharma presents packaging offer at CPHI Milan 2024
Bormioli Pharma, a specialist in pharmaceutical packaging and medical devices, will be present at CPHI Milan (Fiera Milano, booth 20A2) from 8-10 October. The company will showcase its comprehensive range of plastic and glass containers for the pharmaceutical industry, along…
BLA and Tides to surpass small molecules, CPHI Milan report predicts
Key Highlights: The CPHI Annual Industry Survey reveals that the pharma sector is on the cusp of a major shift, with approvals for complex molecules expected to outpace those for small molecules for the first time. The report predicts…
What Solutum’s collab with pester pac means for pharma packaging
pester pac automation, a system providers for end-of-line packaging solutions, has added Solutum’s sustainable packaging material to its portfolio of alternative packaging solutions, offering a novel, sustainable and scalable option for the packaging industry. Solutum’s film offers a plastic alternative…
Gerresheimer, Stevanato Group and SCHOTT Pharma announce alliance
Gerresheimer, a system and solution provider and a global partner for the pharma, biotech and cosmetic industries, together with Stevanato Group, and SCHOTT Pharma, have announced that they have entered into a strategic industry alliance (“Alliance for RTU”) to support market…
.png?cb=272020cf9e86f45c3cfe205346a87686&w=1200)
Recipharm invests in sterile development capabilities
Key Highlights: Recipharm is expanding its pharmaceutical development capabilities through targeted investments and the integration of advanced technologies. The new investments bolsters its services for early- and late- stage product development in oral solid dosage (OSD), sterile fill & finish…
Stevanato introduces on-body delivery system at CPHI Milan
Key Highlights: Stevanato Group announced the expansion of its Vertiva platform, which will include a 10mL option to be presented at CPHI Milan in October. The platform provides a versatile pre-filled and pre-loaded on-body solution, suitable for highly viscous biological drugs….
Tower launches sustainability hub for lower-impact pharma cold chain
Key Highlights: Tower Cold Chain has launched a sustainability hub for customers, highlighting how its consultative, pragmatic approach to pharmaceutical cold chain requirements can help to minimise waste and deliver improved sustainability. The knowledge hub collects Tower’s existing blogs,…
.png?cb=fd48fbe55152d277784caf833826dac5&w=1200)
Behind the scenes: 35 years of CPHI
Ahead of next month’s CPHI Milan – where the industry is expected to turnout in record numbers with a astounding 62,000 pharma executives expected from more than 100 countries – EPM got a sneak preview of what to expect at the event from…
Broughton upgrades online tool to fast-track toxicological assessments
Key Highlights: Broughton has launched the latest version of Tox HQ, an online data-driven tool that allows customers to confidentially submit its products for toxicological assessment. Tox HQ includes the visibility of a product’s ingredients and hazards and utilises…
SHL Medical’s Elexy advances drug-device development
Key Highlights: SHL Medical has adopted a new reusable electromechanical autoinjector Elexy which changes how new drugs are trialled and commercialised, shortening these processes. The integration of SHL’s Needle Isolation Technology for cartridge-based delivery enhances Elexy’s control over factors like cannula gauge…
Acumen and Lonza expand collaboration for early Alzheimer’s drug
Key Highlights: Acumen Pharmaceuticals extends its collaboration with Lonza to add drug product manufacturing for early Alzheimer’s disease. The agreement builds upon a successful collaboration supporting the manufacture of sabirnetug (ACU193) drug substance (DS) for clinical studies in Alzheimer’s disease….
.png?cb=1fb18a72df69bfb121cc2616c54a75a2&w=1200)
Recipharm and Exela announce exclusive strategic alliance for sterile manufacturing
Key Highlights: Recipharm and Exela Pharma Sciences announced an exclusive strategic alliance aimed at enhancing sterile manufacturing capabilities in the United States. This collaboration will provide Recipharm with access to Exela’s manufacturing facility located in Lenoir, North Carolina. Recipharm will add…
European Pharmaceutical Manufacturer – Sept/Oct 2024
The Sept/Oct 2024 issue of EPM Magazine explores the latest insights on regulations, digital health and coatings plus a cover story from SML Medical.
DeSci Labs launches novelty scores for scientific manuscripts
Key Highlights: DeSci Labs has released a new mathematical model scores feature which is an objective measure of novelty for scientific work, now available to the public. The release of these novelty scores for over 250 million scientific articles by DeSci Labs…
Envision Pharma Group launches EnvisionOne Insights
Envision Pharma Group has launched its new data and analytics management solution, EnvisionOne Insights. This represents a foundational shift in how clients can access and optimise their data using Envision’s suite of technology products. The solution channels complex data into one…
Antares Vision Group to debut serialisation station for pharma bottles at Pack Expo
Antares Vision Group, a technological partner in the digitalisation of products and supply chains for companies and institutions, will introduce a new traceability solution for pharmaceutical bottles at Pack Expo, 3-6th November in Chicago. At its Booth S-3754, the company will debut…
Berry to showcase patient-centric drug delivery solutions at CPHI 2024
Berry Global Healthcare will showcase its latest innovations in sustainable pharmaceutical packaging and drug delivery solutions at CPHI Milan 2024, including the launch of a new polypropylene (PP) alternative to PET pill jars. As a circular leader in patient-centred pharmaceutical…
AMP and AHS showcases material handling solutions at PPMA
Advanced Material Processing (AMP) and Automated Handling Solutions (AHS), will combine to showcase the latest material handling and processing innovations on stand F54 at the PPMA show, on 24-26th September at Birmingham’s NEC. For AMP, Kason will have their centrifugal…
PCI Pharma Services invests over $365 million in EU and US facilities
PCI Pharma Services, (“PCI”) a global contract development and manufacturing organisation (CDMO) focused on biopharma’s most complex therapies, is investing more than $365 million in infrastructure supporting the clinical and commercial-scale final assembly and packaging of drug-device combination products utilising…
Europlaz Celebrates 20% Sales Boost Following £3.5M Investment
Following the completion of its three-year, £3.5 million investment, Europlaz is celebrating a 20% (year-on-year) sales growth. As part of its investment strategy, the contract manufacturing specialists recently invested in three all-electric injection moulding machines, worth £750,000, to meet growing…
.jpg?cb=e0f7ca32930a7c05fd5ccab70af9b781&w=1200)
ReZorce circular packaging takes gold in german packaging prize
At the Fachpack exhibition on 24th September, Zotefoams received one of only five Gold prizes awarded by the Deutsche Verpackungsinstitut (dvi) in this year’s German Packaging Prize competition – from a total of 250 entries across 13 countries. The Gold Award…
Thrombolytic Science Receives FDA Investigational New Drug Clearance
Thrombolytic Science (TSI) has received approval from the US Food and Drug Administration (FDA) regarding its Investigational New Drug application. Said application relates to the clinical-stage biotech company’s mutant for prourokinase (mproUK), a recombinant fibrinolytic pro-enzyme. This reconfirms the safety…
Tiziana Life Sciences Secures $4M Grant for Alzheimer’s Disease Study
Tiziana Life Sciences (Tiziana) will receive a $4 million grant from the National Institutes of Health (NIH), the National Institute of Aging. The grant was awarded to Dr Howard Weiner, the Principal Investigator at the Brigham and Women’s Hospital. This…
Barinthus Bio intiates Phase 1 clinical trial of VTP-1000 for treatment of coeliac disease
Barinthus Biotherapeutics plc, a clinical-stage biopharmaceutical company developing novel immunotherapeutic candidates that guide T cells to control disease, has announced the initiation of its first-in-human Phase 1 trial of VTP-1000 in adults with coeliac disease. The randomised, placebo-controlled clinical trial,…
ProBiotix Health Partners Eifron to Expand its Global Footprint
ProBiotix Health Plc (ProBiotix) enters a commercial partnership with Greek-based consumer brand specialist, Eifron SA (Eifron). The life sciences company hopes that the move will successfully expand its global footprint. Through the partnership, Eifron will add YourBiotix, containing ProBiotix’s proprietary…
Three new life science start-ups thrive at Discovery Park
A group of former Pfizer employees have successfully created their own businesses based at and supported by Discovery Park, a thriving life sciences community in Kent. The new businesses are all contract research organisations, namely Biowaived, Matheus Engineering and Particology…
Vicebio Announces $100M Series B Financing for Clinical Study of RSV/hMPV Bivalent Vaccine
Vicebio Ltd has revealed a successful Series B financing of $100 million led by TCGX. The investment comes from Goldman Sachs Alternatives, Avoro Ventures, venBio, as well as UniQuest and founding investor Medicxi. Additionally, Cariad Chester (Managing Partner at TCGX),…
Gerresheimer receives EcoVadis Gold rating
EcoVadis evaluates the management systems of companies in the categories of environment, labour and human rights, ethics and sustainable procurement. More than 130,000 companies worldwide have their sustainability performance assessed by EcoVadis. In 2024, Gerresheimer was amongst the top 3%…
Life science startups grow business through Discovery Spark
Science and innovation campus, Discovery Park, in Sandwich, Kent has launched applications for the third cohort of its business growth competition, ‘Discovery Spark’. The programme equips early stage life science and technology businesses with the skills and tools to lay…
Recipharm launches platform for Quality by Design
Recipharm announced the launch of ReciPredict, a platform for Quality by Design (QbD), designed to transform the landscape of drug product development, tech transfer and manufacturing. With its combination and systematic application of material sciences, statistical tools and modelling and…
TekniPlex Healthcare to highlight new solutions for single-use bioprocessing
TekniPlex Healthcare, which utilises advanced materials science expertise to help deliver better patient outcomes, will emphasise its expertise and intellectual property related to single-use bioprocessing cell & gene therapy at CPHI Milan, 8-10th October. At its Stand 20C2, the company…
Top pharma packaging trends for the future
Dexter Tjoa, CEO of Tjoapack explores the innovations set to transform secondary pharmaceutical packaging from 2024 onwards. Enhancing the patient experience Patient centricity is one of the major themes in both drug formulation development and in packaging at the moment,…
Renovos Biologics Appoints New Non-Executive Director
Renovos Biologics (Renovos) has announced the appointment of its new Non-Executive Director, Lisa Ferrara, Ph.D. Dr Ferrara, who has an extensive amount of experience in helping new orthopaedic devices obtain regulatory approval in the US, joins the Board as the…
Biocomposites Gains Full Control of the SYNICEM and Subiton Product Ranges
Biocomposites has announced that it has acquired the remaining shares in Laboratories SL S.A. and Synergie Ingénierie Médicale S.A.R.L. This allows the medical devices company to gain full control of the SYNICEM and Subiton product ranges. Manufactured in-house, the SYNICEM…
Bormioli Pharma and Asamedic announce partnership for ‘life-saving’ drug Coxor
Asamedic, a pioneer in emergency medical treatment of myocardial infarction, and Bormioli Pharma, a leader in pharmaceutical packaging solutions, have announced a partnership for the commercialisation of Coxor 300mg Acetylsalicylic acid, a ‘revolutionary life-saving medication’ designed for emergency treatment of suspected acute…
MM Packaging to Discuss Market Trends, Challenges, and Solutions at CPHI 2024
MM Packaging has outlined its agenda for the CPHI 2024 show. The secondary packaging specialists will be on hand to discuss a variety of packaging solutions that can be utilised both domestically and internationally. Walter Würfel, VP of Sales &…
Molex to acquire Vectura Group Limited, expanding drug delivery capabilities in inhalation
Molex, a parent to Phillips Medisize, has announced that, through its affiliate Molex Asia Holdings LTD., it has signed an agreement to purchase Vectura Group Limited from Vectura Fertin Pharma Inc., a subsidiary of Philip Morris International. Vectura is a leader in…
Moderna Admits Being ‘Overly Optimistic’ regarding Respiratory Syncytial Virus Vaccination
After winning approval for its respiratory syncytial virus (RSV) vaccination, Moderna has acknowledged that it has been more difficult than expected to win market share from its two key rivals in this field. In May, Moderna received FDA clearance (regarding…
Ellorarxine shown to reduce neuronal death in neurodegenerative disease models
A peer reviewed study published in Frontiers in Neuroscience by academics at Aberdeen and Durham Universities has shown that Ellorarxine, a novel drug compound developed by biotech spinout Nevrargenics, has shown a robust neuroprotective effect in cultured cells and reaches its target…
Richter BioLogics Opens Cutting-Edge Biopharmaceutical cGMP facility
Richter BioLogics GmbH & Co KG (Richter BioLogics), the microbial biologics affiliate of Gedeon Richter PLC , has opened a new cutting-edge biopharmaceutical cGMP facility. Located in Bovenau, the new facility was opened on the 13th of September, and features cutting-edge technology for…
DevCo completes €616 million capital raise for investment in Medix Biochemica
DevCo Partners Ltd has announced a capital raise resulting in 616 million EUR of total commitments for its long-term single asset investment vehicle for Medix Biochemica. The transaction, as part of which ca. 300 million EUR of new investments were raised…
Bayer launches new healthy-ageing ecosystem for consumers
Combining a scientifically formulated dietary supplement, a wellness companion app, and a saliva-based a biological age test by Chronomics, Bayer is taking a step in the emerging healthy-ageing space by offering consumers new tools to help them support their healthy-ageing…
NanoSyrinx closes £10 million financing round and appoints new chairman
NanoSyrinx, a synthetic biology company developing nanosyringes as a novel platform for targeted intracellular delivery of biologic therapeutics, has announced that it has closed a 10 million GBP (13 million USD) financing round. The funding will support further advancement of…
Owen Mumford extends long-standing logistics partnership with Davies Turner
Owen Mumford, a company in the design, manufacture, and advancement of medical devices, has renewed its long-standing logistics partnership with Davies Turner for an additional three-year term. The renewed contract, which emphasises a long-term commitment, will continue to see Davies Turner…
.png?cb=8781b1577dd3b75a9d6ad22472c7549a&w=1200)
BGS Beta-Gamma-Service announces US expansion plans
BGS Beta-Gamma-Service, a specialist for more than 40 years in the use of beta and gamma rays for radiation sterilisation for medical devices, pharmaceutical packaging, and biotechnology products, will open its first facility in the United States next year. The new…
OncoHost accepted to present poster at ESMO 2024
OncoHost, a technology company transforming the approach to precision medicine for improved patient outcomes, has announced its selection to present a poster at the European Society of Medical Oncology (ESMO) Congress 2024, which will take place from 13-17th September 2024, in Barcelona,…
Biocomposites Confirms NanoBone UK Distribution
Biocomposites announces its distribution of the NanoBone product range in the UK. The international medical devices company will supply the NanoBone SBX Putty and NanoBone QD products which provide synthetic bone grafts for reliable, early osteogenesis and bone formation. Dr Walter Gerike,…
Arrowhead Pharmaceuticals’ Plozasiran Receives Breakthrough Therapy Designation from the FDA
Arrowhead Pharmaceuticals has been granted breakthrough therapy designation from the US Food and Drug Administration (FDA) regarding its potential RNA interference (RNAi) therapeutic, plozasiran. The treatment is said to have shown “promising results” in trials by reducing triglycerides and other atherogenic…
New collaboration set to integrate cryoFIL platform with Constellation robotic system
Cellular Origins, a TTP Company, focused on enabling scalable, cost-effective, and efficient manufacture of cell and gene therapies (CGTs), has announced a collaboration with 3P innovation, a leading engineering company and supplier of automated fill-finish equipment. The partnership will integrate…
BIOCAPTIVA Granted First US Patent for Liquid Biopsy Technology
BIOCAPTIVA has been awarded its first US patent for its liquid biopsy technology. The solution aims to efficiently capture cell-free DNA (cfDNA) directly from bodily fluids. As a result, the biotech company hopes to improve early disease detection, treatment monitoring,…
ILC Therapeutics completes £2.5m financing round and bolsters C-suite
ILC Therapeutics, a specialist developer of hybrid interferons, a new drug class engineered for improved therapeutic profiles across multiple indications, has announced that it has successfully completed a fundraise of 2.5 million GBP. The fundraise, led by St Andrews-based impact investment…
Novartis Set for Major Expansion to Meet Radiopharmaceutical Demands
Novartis, a developer of radiopharmaceuticals currently selling Pluvicto and Lutathera to treat prostate and digestive tract cancers, has announced its upcoming expansion plans. Joining the company’s current facilities in New Jersey and Indianapolis, Novartis will break ground on a new…
NanoSyrinx closes £10 million financing round and appoints new chairman
NanoSyrinx, a synthetic biology company developing nanosyringes as a novel platform for targeted intracellular delivery of biologic therapeutics, today announced that it has closed a 10 million GBP (13 million USD) financing round. The funding will support further advancement of…
Chiesi Group Announces New Senior Vice President of Global Communications & Public Affairs
The Chiesi Group has revealed its new Senior Vice President of Global Communications & Public Affairs, Lauren Vergani. Vergani, who has previously held senior roles at leading global companies such as Walgreens Boots Alliance, Barclays, and Standard & Poor’s, most…
Newcells Biotech launches Lung Ciliary Beat Frequency assay
Newcells Biotech, a leading drug discovery partner specialising in the development of in vitro models and bespoke assay services to improve the prediction of in vivo human outcomes, has announced the launch of its proprietary CiliaBeat software and application in a Lung Ciliary Beat Frequency…
Gerresheimer presents prefillable syringe systems at CPHI Worldwide
Gerresheimer will be presenting its silicone oil-free prefillable syringe systems for ophthalmic applications at CPHI Worldwide 2024. The syringe systems made of glass or plastic are designed for maximum compatibility even for sensitive ophthalmic drugs and offer “outstanding” functionality with…
Could GenAI take over regulatory dossier creation?
Renato Rjavec, ArisGlobal, discusses how generative AI (GenAI) technology is transforming everyday regulatory and safety processes, thanks to its ability to summarise key insights and findings from across huge, diverse bodies of content and data. Pilot solutions can now help…
AMP introduces TotalClean CIP systems
Automated Material Processing (AMP), comprising Kason Corporation and Marion Process Solutions, has recently introduced its TotalClean Clean-in-Place (CIP) systems. These CIP solutions are designed to increase efficiency, safety and profitability across a range of industries including pharmaceutical, all while meeting validation of…
Home pin-prick blood test launches that can predict dementia risk
A new home pin-prick blood test, The Glutathione Index test, has launched – and it can predict dementia risk. Your brain consumes more energy than any other organ. This combustion creates exhaust – oxidants – that age your brain. These…
BlueRock Therapeutics announces FDA clearance
BlueRock Therapeutics, a clinical stage cell therapy company and wholly owned, independently operated subsidiary of Bayer, has announced the clearance of its Investigational New Drug (IND) application by the U.S. Food and Drug Administration (FDA) for OpCT-001, an investigational induced pluripotent…
J&J Submits Autoantibody-driven Disease Treatment for FDA Approval
Johnson & Johnson (J&J) has submitted its nipocalimab drug for approval from the US Food and Drug Administration (FDA). While the initial submission relates to use with patients with generalised myasthenia gravis, the company believes it could go on to treat…
Novavax Covid-19 Vaccine Receives Emergency FDA Approval
Novavax has announced that it has received emergency use authorisation (EUA) from the US Food and Drug Administration (FDA). The ruling relates to the updated version of its Covid-19 vaccine, NVX-CoV2705. This news follows similar decisions from the FDA regarding…
Vetter’s European clinical site successfully completes first 100 aseptic fills
Vetter, a leading global contract development and manufacturing organisation (CDMO), has successfully completed the first 100 clinical batches of liquid and lyophilised vials at its dedicated site in Rankweil, Austria. Vetter Development Services Austria supports the manufacturing and quality control…
.jpg?cb=cabd9aab19391b14f46712901e3eb58f&w=1200)
Moderna Receives MHRA Authorisation for Updated Covid-19 Vaccine
The Medicines and Healthcare Products Regulatory Agency (MHRA) has given its authorisation of Moderna’s updated Covid-19 vaccine. The latest innovation of the vaccine aims to target the JN.1 variant of SARS-CoV-2. Doses of the new vaccine will be available as…
SeaBeLife receives Orphan Drug Designation from EMA for acute liver failure treatment
SeaBeLife, a biotechnology company developing drug candidates intended to block cellular necrosis, has announced the granting of an Orphan Drug Designation (ODD) by the European Medicines Agency (EMA) for its drug candidate SBL01 in the treatment of acute liver failure. Acute…
Novartis Gives $20M to Lindy Biosciences to Improve Biologic Delivery
Novartis and Lindy Biosciences sign a licensing and collaboration agreement that will improve biologic delivery. The North Carolina-based biotech company will help deliver biologics via subcutaneous (SC) injections, which can be self-administered at home. As part of the agreement, Novartis…
Antabio completes Phase 1 clinical study of MEM-ANT3310 for severe hospital infections
Antabio, a private biopharmaceutical company developing novel and highly differentiated antibacterial treatments for critical priority pathogens, with a particular focus on life-threatening respiratory infections, has announced that it has completed the Phase 1 clinical trial for MEM-ANT3310 in healthy volunteers….
NuCana Discontinues Study into Colorectal Cancer Treatment
NuCana plc (NuCana) will discontinue its NuTide:323 study after a pre-planned initial analysis and recommendation from the NuTide:323 Study Steering Committee deemed that it was “unlikely to achieve the study’s primary objective of superior progression-free survival” compared to other treatments. However,…
BioPhorum acquires training organisation Brookwood Global
BioPhorum has announced the acquisition of Brookwood Global, a UK-based provider of training and educational content for professionals operating in the field of clinical research. BioPhorum has been at the heart of the biopharmaceutical industry for more than 15 years. Trusted…
The FemTech Series: The effects of osteoporosis in women
In this episode of The FemTech Series, Olivia Friett, the editor of Medical Plastics News is joined by Cat Kelly, chief operating officer at Naitive, to discuss how 75% of cases of osteoporosis, a condition that affects one in three…
Masterpress responds to sustainability trends in the packaging industry
Masterpress, a European provider of printed decorative packaging solutions, will exhibit at FACHPACK, the international European trade fair for packaging, technology and processing, between 24-26th September, in Nuremberg, Germany. At the event, Masterpress will present products and advanced technologies that demonstrate…
ApiJect Systems Corp to Receive $35M from Trinity Capital Inc
Trinity Capital Inc. has announced that it is committing $35 million in equipment financing to medical technology company, ApiJect Systems Corp (ApiJect). The Stamford-based company specialises in prefilled, single-dose injection devices and works with pharmaceutical companies to design scalable, cost-efficient…
PCI Pharma Services’ Bedford completes ICMRA inspection
PCI Pharma Services (PCI), a global contract development and manufacturing organisation (CDMO), has completed the International Coalition of Medicines Regulatory Authorities (ICMRA) inspection of its Bedford, New Hampshire campus. In doing so, PCI becomes the first drug product CDMO to…
Pfizer Launches Direct-to-Consumer Service – European Pharmaceutical Manufacturer
Pfizer has unveiled its direct-to-consumer service which will help users schedule telehealth appointments, fill prescriptions, and access saving programs for the company’s COVID-19, migraine, and influenzas treatments. Dubbed PfizerForAll, people will also be able to schedule vaccinations for diseases including pneumococcal…
Mestag Therapeutics awarded £1.5m Innovate UK grant to accelerate the Path to Clinic for MST-0300
Mestag Therapeutics, a biotech company harnessing new insights into fibroblast-immune interactions, has announced that it has been awarded a “Transforming Cancer Therapeutics” grant from Innovate UK’s Cancer Therapeutics program of 1.5 million GBP (1.9 million USD) to accelerate the development…
Alzheimer’s Disease Drug Deemed Too Expensive for the NHS
Even though the UK became the first country to authorise the use of Eisai and Biogen’s Leqembi (lecanemab) Alzheimer’s disease drug, the treatment has been deemed too expensive for the NHS. The National Institute for Health and Care Excellence (NICE),…
MSD acquires B-Cell depletion therapy CN201 from Curon Biopharmaceutical in $1.3B deal
MSD and Curon Biopharmaceutical (Curon), a privately held biotechnology company, have announced that they have entered into a definitive agreement under which MSD, through a subsidiary, has agreed to acquire CN201, a novel investigational clinical-stage bispecific antibody for the treatment…
FDA Approves mRNA Covid-19 Vaccines Targeting Omicron Variant KP.2 Strain
Moderna and Pfizer-BioNTech’s updated mRNA Covid-19 vaccines, Comirnaty and Spikevax, have received approval and emergency use authorisation (EUA) from the US Food and Drug Administration (FDA). Both vaccines have been specifically formatted to combat the Omicron variant KP.2 strain of…
Using AI to accurately analyse blood samples
In this episode of The MedTalk Podcast, you can hear Olivia Friett, editor of Medical Plastics News talk to Dr. Murdoc Khaleghi, chief medical officer for Molecular You about the latest technology in AI driven blood testing and how it can…
Hapman highlights next-generation Helix Flexible Screw Conveyor
Hapman highlights its Helix Flexible Screw Conveyor, a solution engineered to enhance efficiency in material transport for the pharmaceutical industry. The Helix Flexible Screw Conveyor is designed to excel in a multitude of applications, from bulk material transport to precise batching and blending, effectively…
Adcendo ApS and Multitude Therapeutics Inc Sign Licensing Agreement for an ADC Drug Candidate Targeting Tissue Factor
Adcendo ApS (Adcendo) and Multitude Therapeutics Inc (Multitude) have signed a licensing agreement regarding the development of a highly differentiated antibody-drug conjugate (ADC) targeting Tissue Factor (TF), known as ADCE-T02. As part of the agreement, Adcendo gains exclusive development and…
Sensitive detection of cell culture mycoplasma infection
The MycoScope Mycoplasma PCR detection kit from AMSBIO uses polymerase chain reaction (PCR) technology to detect mycoplasma infections in less than 3 hours. Offering high-sensitivity detection, rapid results, and compatibility with existing PCR setups, this kit reduces the risk of contamination spread saving valuable time…
MEDICAL JAPAN 2024 TOKYO expands with new trade fairs
MEDICAL JAPAN TOKYO returns to Makuhari Messe from 9-11th October, covering everything related to the medical, elderly care, pharmacy, and healthcare sectors and introducing more than seven new trade fairs. Like in the previous edition, MEDICAL JAPAN TOKYO features six sub…
.jpg?cb=7487e7bf7a0c68ba8755df3528ff0f86&w=1200)
How can manufacturers advance fluidised bed dryers
Alan Messenger, sales director at Optimal Industrial Automation, looks at how manufacturers and processors can advance their fluidised bed dryers to enhance competitiveness and profitability. Offering a highly efficient drying method, FBDs play a fundamental role in various manufacturing industries,…
Leqembi authorised for early Alzheimer’s in the UK
Eisai Co., Ltd. and Biogen Inc have announced that the humanised amyloid-beta (Aβ) monoclonal antibody Leqembi (Lecanemab) has been granted a Marketing Authorisation by the Medicines and Healthcare products Regulatory Agency (MHRA) in Great Britain. Lecanemab is indicated for the treatment of…
SGS Introduces New Specialised Bioanalytical Testing Services in North America
SGS is set to release new specialised bioanalytical testing services in North America. The new services can be used in both pharmaceutical and biopharmaceutical applications and will be delivered from a laboratory located in Hudson, New Hampshire. The new services will support discovery, pre-clinical…
Everest Medicines announces Investigator-Initiated Clinical Trial for cancer vaccine programme
Everest Medicines has announced the launch of an Investigator-Initiated Clinical Trial (IIT) for a personalised mRNA cancer vaccine, EVM16, under the study EVM16CX01, at the Peking University Cancer Hospital and Fudan University’s Cancer Hospital. The trial is designed to assess the…
Novo Nordisk to meet Drug Demand with $220M Expansion
A subsidiary of Novo Nordisk is set to make a $220 million (1.5 billion Danish Kroner) expansion at its existing site in Køge, Denmark. The planned development, believed to span around 8,000 square metres, is being made to support drug…
Abselion announces £1.1m project to develop next-gen cell platform for viral vector production
Biotechnology companies and research organisations in the UK and Canada are entering into a R&D project jointly funded by a 1.1 million GBP grant from Innovate UK and the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP)….
The importance of micromoulding in diabetes devices
A.J. Pruitt, technology manager at Accumold discusses the impact of the company’s successful drive towards the efficient micromoulding of previously extruded thin walled cannulas, and what this means for industry. Q. Can you explain the pivotal role thin-walled cannulas play…
Why Pharmaceutical Industry Needs a Digital Content Factory (DCF)?
Viacheslav Vasylenko, Сo-Founder & Chief Operating Officer, Viseven discusses digital content factories and why they are essential for pharma companies today. Modern pharma brands pursue a higher degree of content personalisation to engage with diverse audiences. This means tighter deadlines,…
QuantaMatrix Develops “the World’s Fastest” All-in-One Antimicrobial Testing Technology
QuantaMatrix has unveiled what it’s calling “the world’s fastest” all-in-one antimicrobial testing technology. The uRAST (ultra-rapid antimicrobial susceptibility testing) solution has recently been published in the scientific journal, Nature. Traditionally, antimicrobial testing methods can take days to complete, often taking…
MHI to demo small-batch blister machine at Pack Expo
Maruho Hatsujyo Innovations (MHI) will showcase a blister machine specifically intended for stability testing, clinical trials and similar small-run applications at Pack Expo Booth W-15058, 3-6th November in Chicago. The Eagle-LP – short for “Lab Pack” – joins the company’s extensive…
AstraZeneca and Daiichi Sankyo Receives Chinese Approval for Gastric Cancer Therapy
AstraZeneca and Daiichi Sankyo have announced that the duo’s antibody-drug conjugate (ADC), Enhertu (trastuzumab deruxtecan), has received conditional approval from the China National Medical Products Administration (NMPA) for gastric cancer. Now, Enhertu can be used as a single agent for adults with…
Oncimmune Holdings wins $1.5m contract with top 10 pharma company
Oncimmune Holdings plc, a leading autoantibody profiling company providing research services to the pharmaceutical and biotechnology industry to enable the delivery of precision medicine, has announced a new contract win with a top 10 global pharma company. Following a successful…
Kerato uses partnership to develop corneal damage treatment
Kerato has entered into a Heads of Terms agreement and research partnership with the University of Montreal in Canada. BSF’s 100% owned Kerato is an independent company established to commercialise new innovations in tissue engineering towards in vitro and in…
Atopic dermatitis treatment sees promising future with new drug approvals
Atopic dermatitis (AD) is experiencing a transformative shift in treatment management with recent drug approvals that address critical unmet needs. The introduction of novel therapies, such as Dermavant’s VTAMA (tapinarof) (Japan) and Arcutis’s ZORYVE (roflumilast) (US), with innovative mechanisms of…
OncoHost announces three abstracts selected for presentation at WCLC 2024
OncoHost has announced that three of its research abstracts have been selected for presentation at the upcoming World Conference on Lung Cancer (WCLC 2024). The abstracts highlight OncoHost’s work in developing predictive models for immunotherapy-related toxicities and clinical outcomes. The research…
NorthStar and Convergent Expands Collaboration with its Prostate Cancer Treatment
NorthStar Medical Radioisotopes (NorthStar) and Convergent Therapeutics (Convergent) are set to expand its collaboration relating to the CONV01-a treatment for prostate cancer. The duo explains its new drug by detailing that “CONV01-a is a prostate-specific membrane antigen-targeted monoclonal antibody attached to Ac-225.” As…
NHS requires compliance with BSI Kitemark to promote responsible antibiotic manufacturing
Pharmaceutical companies bidding for the newly launched NHS Antimicrobial Product subscription model will be required to demonstrate the steps they are taking to promote responsible antibiotic manufacturing and minimise the risk of antimicrobial resistance by certifying to a key antibiotic…
Lykos Therapeutics’ PTSD Treatment Receives Rejection from the FDA
Lykos Therapeutics (Lykos) has received a rejection from the US Food and Drug Administration (FDA) regarding its midomafetamine (MDMA) treatment for post-traumatic stress disorder (PTSD). Upon rejecting the treatment due to the “data submitted to date,” the FDA asked Lykos…
Alcura obtains manufacturing and importation authorisation license
Alcura, a provider of specialised clinical trial services and a part of Cencora, has been granted a Manufacturing and Importation Authorization (MIA) license for cell and gene therapies (CGT) by the Spanish Agency of Medicines and Medical Devices. The certification,…
Champalimaud Foundation Installs a Lonza MODA-ES Platform at its Clinical Centre
Champalimaud Foundation has decided to install one of Lonza’s MODA-ES Platforms at its Champalimaud Clinical Centre in Lisbon, Portugal. The biomedical clinical research organisation has opted to install MODA-ES as it hopes to improve and streamline the cell therapy manufacturing…
Triastek signs agreement with BioNTech for 3D printed RNA therapeutics
Triastek has announced that it has entered into a research collaboration and platform technology license agreement with BioNTech SE, a next generation immunotherapy company pioneering novel therapies for cancer and other serious diseases. Under the agreement, the companies will develop RNA…
Amneal Receives FDA Approval for Parkinson’s Treatment
Amneal Pharmaceuticals has received approval from the US Food and Drug Administration (FDA) for its CREXONT extended-release capsules for Parkinson’s disease (PD) treatment. The oral carbidopa (CD)/levodopa (LD) formulation that makes up CREXONT aims to provide patients with a more…
Oncimmune Holdings wins $1.5m contract with top 10 pharma company
Oncimmune Holdings plc, a leading autoantibody profiling company providing research services to the pharmaceutical and biotechnology industry to enable the delivery of precision medicine, has announced a new contract win with a top 10 global pharma company. Following a successful…
.jpg?cb=68128e1a304b7984acf4bad2c83805c2&w=1200)
FemTech Series: Finding support for Endometriosis
In this episode of The FemTech Series on The MedTalk Podcast, you can hear Olivia Friett, editor of Medical Plastics News talk to Dearbhail Ormond, founder and CEO at Frendo, where they discuss how endometriosis affects women and how Frendo…
C2N Diagnostics and Unilabs announce global partnership
Unilabs, an international provider of diagnostic services, and C2N Diagnostics have announced a milestone in brain health diagnostics and research across Europe and beyond. Unilabs and C2N have signed a multi-year partnership agreement that will increase access to C2N’s Precivity portfolio of blood tests on…
Cresset collaborates with Enamine to enable the design of new degraders
Cresset, a provider of integrated in silico solutions for drug discovery, announces an extension of the global collaboration with Enamine, a chemical and biological contract research organisation and producer of novel building blocks for drug design, in the area of targeted protein degradation (TPD). …
Vertex announces CASGEVY reimbursment agreement for treatment of transfusion-dependent beta thalassaemia in England
Vertex Pharmaceuticals has announced a reimbursement agreement with NHS England for eligible transfusion-dependent beta thalassaemia (TDT) patients to access the CRISPR/Cas9 gene-edited therapy, CASGEVY (exagamglogene autotemcel), from August 8, 2024. The reimbursement agreement comes as the National Institute for Health and Care…
Optimal Industrial Technologies hosts synTQ User Group Meeting
Optimal Industrial Technologies recently hosted a synTQ User Group Meeting at the FHNW University in Basel, Switzerland, attracting representatives from many of names in the pharmaceutical industry. The event was a great opportunity for users to learn about the latest features…
Improving image integrity in clinical research
Including figures and images in clinical research enables researchers to illustrate their findings in a clear, effective, and engaging way. Despite their importance, it can be difficult to manually check images for accuracy — introducing the risk of integrity issues. Here Dr….
Valneva Scotland Achieves a Silver Award in Health and Safety
Valneva Scotland Ltd, the largest vaccine producer in Scotland, has received the Silver Award for health and safety from the Royal Society for the Prevention of Accidents (RoSPA). This award recognises the high standards of safety and excellence in a…
Beckman Coulter Life Sciences and Illumina launch TruSight Oncology 500 DNA/RNA application
Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, in partnership with Illumina, a leader in DNA sequencing and array-based technologies, has launched the a ‘promising new approach’ to oncology research delivering faster results with fewer touchpoints. The…
Calibre Scientific Acquires Spanish Biotechnology Laboratory Consumables and Equipment Supplier
Calibre Scientific has announced its acquisition of the Spanish distributor of biotechnology laboratory consumables and equipment, ACEFE, S.A.U (ACEFESA). ACEFESA, which is Calibre Scientific’s fifth acquisition in Spain, has an established position in the biotechnology, molecular biology, pharmaceutical, and veterinary…
Pharma manufacturing giant Asymchem opens European HQ at Discovery Park
Asymchem Laboratories (Tianjin) Co., Ltd. has officially inaugurated its new European development and pilot manufacturing site at Discovery Park in Sandwich, Kent, U.K., marked with a ribbon cutting on Friday 2 August, 2024, by Dr. Hao Hong, Chairman, Founder, and CEO…
Easing the scepticism of consumer wearables
In this episode of The MedTalk Podcast, Olivia Friett, the editor of Medical Plastics News, is joined by Esther Rodriguez Villegas, founder of Acurable, where they will discuss the AcuPebble device, the importance of wearables in the sector, how to…
.png?cb=26ed436e6cfd0c3fdf065c8d3cf64b3d&w=1200)
Eisai selects Medidata’s Clinical Data Studio to enhance clinical trial efficiency and patient experience
Medidata, a Dassault Systèmes brand and provider of clinical trial solutions to the life sciences industry, has announced Eisai Inc, the U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., as one of the first customers to harness its recently announced AI-driven…
ACG Packaging Materials Awarded Kepner-Tregoe Excellence Prize
ACG Packaging Materials has won the Kepner-Tregoe (KT) Excellence Award in the category ‘problem-solving’ excellence. The integrated pharmaceutical solutions and manufacturing company has previously been acknowledged in KT’s award prizes when it comes to exceptional results, talent or achievements. On winning…
Cresset integrates Spark in latest release of Flare
Cresset, a provider of integrated in silico solutions for drug discovery announces the release of V9 – the latest version of its Flare platform for ligand-based and structure-based design, which includes a full integration of Spark, Cresset’s bioisostere replacement solution. Flare users…
.jpg?cb=3bac4ca88cfe52b0af3c62f21d7f814d&w=1200)
Packaging innovation: A new era of biopharmaceutical packaging solutions
Packaging is a critical component of pharmaceuticals, protecting the integrity, safety, and efficacy of essential treatments throughout the supply chain and providing tools for product traceability. As a result, the pharmaceutical packaging market is projected to grow from $110.55 billion…
Trelleborg Medical Solutions expands its testing capabilities
Trelleborg Medical Solutions announces the opening of its new 490 square feet/46 square meters laboratory space for analytical testing to support the development of sustained-release and drug-elution technologies. Trelleborg Medical Solutions created the laboratory space to deliver part of…
Angstrom Technology awarded Best Cleanrooms Solutions Company 2024
Global cleanroom solutions provider, Angstrom Technology has received the Best Cleanrooms Solutions Company Award at the International Life Sciences Awards 2024. GHP magazine’s International Life Sciences Awards programme recognises those that are going above and beyond, or indeed, the businesses…
Aurora Cannabis and Vectura Fertin Pharma announce commercial collaboration
Aurora Cannabis Inc., a leading Canadian-based global medical cannabis company, and Vectura Fertin Pharma, Inc., an innovator in wellness and healthcare, have announced that Aurora has entered into a commercial collaboration with Cogent International Manufacturing Ltd., a wholly-owned subsidiary of Vectura…
Freudenberg Expands Biopharma Product Offering to Include Single-use Assemblies
Freudenberg Medical has announced the expansion of its biopharma product portfolio to now include custom single-use assemblies. The new products combine the medical and pharmaceutical device specialist’s expertise in silicone extrusion and moulding. Single-use y-connector manifolds, tubing assemblies, and bottle…
Novo Holdings invests £50 million in Oxford Nanopore Technologies
Novo Holdings, a leading international life science investor, has announced a 50 million GBP investment in Oxford Nanopore Technologies, a leading UK Listed company behind a ‘new generation’ of molecular sensing technology based on nanopores. Novo Holdings will invest the funds in…
Marion and Kason boost blending capacity at Almac Pharma Services
Marion Process Solutions and Kason Corporation – part of Advanced Material Processing (AMP) – have increased the blending capabilities at global headquarters in Northern Ireland. The collaboration marks a milestone in the ongoing partnership between the two companies, showcasing AMP’s…
Polish Ministry of Health approves reimbursment of POTELIGEO for adults with mycosis fungoides
Kyowa Kirin International (KKI), a wholly owned subsidiary of Kyowa Kirin Co. Ltd., and Swixx BioPharma AG has announced that the Polish Ministry of Health has approved the reimbursement of POTELIGEO (mogamulizumab) in second-line monotherapy for adult patients with Stage IB…
Asimov Launches its Fourth Generation AI-driven CHO Edge System
Asimov has unveiled the fourth generation of its AI-driven, CHO Edge System. The platform features an increased typical titer range of 5-11 g/L across modalities before any upstream process optimisation. The synthetic biology specialist hopes the latest edition will further develop the…
CSafe launches reusable Silverpod pallet shipper to help pharma companies reach sustainability targets
CSafe, a provider of active and passive temperature-controlled shipping solutions for the pharmaceutical industry, has announced the launch of a new reusable pallet shipper, the Silverpod MAX RE, with multiple updated features. The new and improved product will help pharmaceutical customers around the…
Bio-Rad Expands its Pioneer Antibody Discovery Platform
Bio-Rad Laboratories has unveiled the latest updates for its Pioneer Antibody Discovery Platform services. Based on the life science research and clinical diagnostics company’s SpyLock technology, the features of fast generation and screening of bispecific antibodies have now been added to…
Otsuka and Oxford HIN collaborate to gather insights into digital therapeutics for mental health
Otsuka Pharmaceutical Europe Ltd. and Otsuka Pharmaceuticals (U.K.) Ltd. (Otsuka) are collaborating with Health Innovation Oxford & Thames Valley (Oxford HIN) to evaluate the implementation and integration of a new digital therapeutic (DTx), CARE for MDD, intended to support the treatment of major depressive disorder…
Calliditas Therapeutics secures full marketing authorisation from the European Commission
Calliditas Therapeutics has announced that it has received full marketing authorisation from the European Commission regarding the biopharma company’s Kinpeygo treatment for adults with primary immunoglobulin A nephropathy (IgAN). This allows for a broader label for patients with primary IgAN, moving…
Lario Therapeutics is Awarded $6M to Aid with Parkinson’s Research
Lario Therapeutics reveals that it has been awarded a $6 million grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF). The programme is in collaboration with the Oxford Parkinson’s Disease Centre (OPDC), which will help deliver key sciences as…
Enterprise Therapeutics Doses First Person with Cystic Fibrosis with ETD001
Enterprise Therapeutics (Enterprise) has successfully administered ETD001 to an individual with Cystic Fibrosis. The biopharmaceutical company is focused on developing therapies to help improve the lives of those suffering from respiratory disease. Today’s announcement is part of Enterprise’s Phase 2a…
Endless Health raises $4.5M series seed
Endless Health, an end-to-end at-home testing and preventive medicine company, has secured $4.5 million in a Series Seed funding round. The round was led by Next Coast Ventures, which was an early investor in Everly Health, and Asset Management Ventures,…